The University of Chicago Header Logo

Connection

Godfrey Getz to Dose-Response Relationship, Drug

This is a "connection" page, showing publications Godfrey Getz has written about Dose-Response Relationship, Drug.
  1. Apolipoprotein A-I alpha -helices 7 and 8 modulate high density lipoprotein subclass distribution. J Biol Chem. 2002 Mar 22; 277(12):9645-54.
    View in: PubMed
    Score: 0.037
  2. The apolipoprotein-AI mimetic peptide L4F at a modest dose does not attenuate weight gain, inflammation, or atherosclerosis in LDLR-null mice. PLoS One. 2014; 9(10):e109252.
    View in: PubMed
    Score: 0.022
  3. A novel potent synthetic steroidal liver X receptor agonist lowers plasma cholesterol and triglycerides and reduces atherosclerosis in LDLR(-/-) mice. Br J Pharmacol. 2011 Apr; 162(8):1792-804.
    View in: PubMed
    Score: 0.018
  4. Mechanism of the growth-related activation of the low density lipoprotein receptor pathway. J Biol Chem. 1989 Jan 25; 264(3):1787-92.
    View in: PubMed
    Score: 0.015
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.